Jason Raleigh Nunn

Director at Zenas Biopharma · 2 reported transactions in 2 companies · latest trade Oct 9, 2025

Their record

Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.

Typical move −22.7%, S&P 500 −2.3% over the same days.


Zenas BiopharmaZBIO	Bought $1.2M · 63,158 shares	Oct 9, 2025	S&P 500 +14.6%thru Oct 29

Oct 9, 2025 · ZBIO

$1.2M

S&P 500 +14.6%thru Oct 29

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.